Orthonotes
Orthonotes
by the.bonestories
v4.1 Fusion X
v4.1 Fusion X
PubMed Original Article Evidence Unclassified

Bone and joint tuberculosis in paediatrics: a 13-year retrospective study.

Journal of medical microbiology | 2022 | Gouveia C, Cabral MF, Jordão P, Campagnolo J

In-App Reader

Open Source

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Source
PubMed
Type
Original Article
Evidence
Unclassified

Abstract

[Indexed for MEDLINE] 6. Joint Bone Spine. 2015 Dec;82(6):417-22. doi: 10.1016/j.jbspin.2015.02.012. Epub 2015 Jul 14. Lymphopenia in early arthritis: Impact on diagnosis and 3-year outcomes (ESPOIR cohort). Duquenne C(1), Cornec D(1), Marhadour T(1), Jousse-Joulin S(1), Cantagrel A(2), Pavy S(3), Devauchelle-Pensec V(1), Saraux A(4). Author information: (1)Rheumatology unit and immunology department (EA 2216), hôpital de la Cavale-Blanche, CHU de Brest, université Bretagne occidentale, BP 824, 29609 Brest cedex, France. (2)Rheumatology unit, Toulouse university hospital, 31059 Toulouse cedex 9, France. (3)Rheumatology unit, Bicêtre hospital, 94275 Le-Kremlin-Bicêtre, France. (4)Rheumatology unit and immunology department (EA 2216), hôpital de la Cavale-Blanche, CHU de Brest, université Bretagne occidentale, BP 824, 29609 Brest cedex, France. Electronic address: Alain.Saraux@chu-brest.fr. OBJECTIVES: In patients with early arthritis naive to disease-modifying antirheumatic drugs, we evaluated the prevalence of initial and persistent lymphopenia, underlying diagnoses, and risk of infection or malignancy. METHODS: Eight hundred and thirteen patients with early arthritis included in the ESPOIR cohort had a clinical examination, laboratory tests (viral serology, immunological tests, and cytokine profile), and radiographs. We determined the prevalence of lymphopenia at baseline and after 3 years, associated factors, diagnoses, and risk of infection or malignancy. RESULTS: At baseline, 50/813 (6.2%) patients had lymphopenia. Lymphopenia was associated with positive rheumatoid factor (P=0.02), cytopenia (P≤0.05), hepatitis C (P=0.05), higher C-reactive protein and DAS28 (P≤0.05 for both). Cytokine profile and radiological progression were not significantly different between patients with and without lymphopenia. Suspected diagnoses at inclusion were rheumatoid arthritis (RA, n=27), unclassified arthritis (n=15), systemic lupus erythematosus (SLE, n=3), spondyloarthritis (n=2), Sjögren's syndrome (n=1), hematologic disease (n=1), and fibromyalgia (n=1). Fifteen patients out of 42 (35.7%) with initial lymphopenia had persistent lymphopenia after 3 years, including 5 with documented causes (lupus, hepatitis C, undernutrition, azathioprine, and tamoxifen); none had PVB19, HIV, or HBV infection and none experienced infections, solid or hematologic malignancies during follow-up. Final diagnoses in these 15 patients were RA (n=6), unclassified arthritis (n=6), SLE (n=1), spondyloarthritis (n=1), and fibromyalgia (n=1). CONCLUSIONS: Lymphopenia is rare in early arthritis. The most common rheumatic cause is RA, in which marked inflammation and other cytopenias are common. Lymphopenia in early arthritis is often short-lived, even when methotrexate is prescribed. Copyright © 2015. Published by Elsevier SAS. DOI: 10.1016/j.jbspin.2015.02.012

Linked Wiki Topics

This article has not been linked to a wiki topic yet.

Linked Cases

This article has not been linked to a case yet.

Linked Atlases

This article has not been linked to an atlas yet.